Alvotech (ALVO) Total Current Liabilities (2020 - 2026)
Alvotech's (ALVO) quarterly Total Current Liabilities came in at $331.2 million in Q2 2026, up 18.38% on a YoY basis from $279.7 million in Q2 2025, and up 27.48% quarter-over-quarter from $259.8 million in Q1 2026.
Analysis
Alvotech (ALVO) Total Current Liabilities (2020 - 2026) Analysis & Trends
Alvotech (ALVO) has reported Total Current Liabilities for 7 consecutive years, with $331.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Total Current Liabilities rose 18.38% year-over-year to $331.2 million; the trailing twelve-month figure through Jun 2026 stood at $331.2 million (up 18.38% YoY), and the FY2025 full-year result was $304.1 million, up 57.23% from the prior year.
- Total Current Liabilities rose to $331.2 million in Q2 2026 per ALVO's latest filing, from $259.8 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.2 billion in Q2 2024 and bottomed at $160.5 million in Q3 2024.
- Historically, Total Current Liabilities has averaged $319.7 million across 5 years, with a median of $263.4 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities soared 442.4% in 2024, then plunged 76.74% in 2025.
- Over 5 years, Total Current Liabilities stood at $167.3 million in 2022, then soared by 55.98% to $261.0 million in 2023, then fell by 25.89% to $193.4 million in 2024, then soared by 57.23% to $304.1 million in 2025, then climbed by 8.91% to $331.2 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $331.2 million, $259.8 million, and $304.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 15.65 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 6.35 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 1.66 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 883.19 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 4.54 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 283.66 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 331.18 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 263.21 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 12.39 Mn |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | 907,048.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 331.18 Mn |
| Mar 31, 2026 | 259.78 Mn |
| Dec 31, 2025 | 304.08 Mn |
| Sep 30, 2025 | 304.07 Mn |
| Jun 30, 2025 | 279.75 Mn |
| Mar 31, 2025 | 265.81 Mn |
| Dec 31, 2024 | 193.40 Mn |
| Sep 30, 2024 | 160.55 Mn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 246.79 Mn |
| Dec 31, 2023 | 260.95 Mn |
| Jun 30, 2023 | 221.69 Mn |
| Dec 31, 2022 | 167.29 Mn |
| Jun 30, 2022 | 277.79 Mn |
| Dec 31, 2021 | 111.84 Mn |
| Dec 31, 2020 | 50.98 Mn |